Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Better Cannabis Stock: HEXO vs. OrganiGram

Published 07/15/2021, 09:17 AM
Updated 07/14/2021, 11:30 PM
© Reuters.  Better Cannabis Stock: HEXO vs. OrganiGram

The cannabis industry is expected to see impressive growth in the next 5 years. With that in mind, which cannabis stock, HEXO Corp. (NYSE:HEXO) or OrganiGram Holdings Inc. (NASDAQ:OGI), is currently the better buy?.According to Mordor Intelligence, the cannabis market is expected to grow at a CAGR rate of 18.1% between 2021 and 2026. This solid growth rate is expected to be fueled by the proven medicinal usage of cannabis, legalization of cannabis at a higher pace, and further diversification of the cannabis products portfolio.

The cannabis market remains highly volatile amid investors’ concerns regarding negative profitability and rapid increase in competition in the given market. As a result, the ETFMG Alternative Harvest ETF (MJ) lost around 10% over the past month compared to SPDR S&P 500 Trust ETF (SPY) 3% gains over the same period.

Keeping that in mind, today we're going to analyze and compare two cannabis stocks: HEXO Corp. (HEXO) and OrganiGram Holdings Inc. (OGI). HEXO is headquartered in Kanata, Canada, and produces, markets, and sells cannabis in Canada. OGI, which is based in Moncton, Canada, produces and sells cannabis and offers a variety of cannabis-related products such as extracts, oils, beverages, and others.

Continue reading on StockNews

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.